MINAKAWA YASUYUKI 皆川康之

Researcher Number	30639787
Affiliation (based on the past Project Information) *help	2016 – 2019: 千葉大学, 大学院医学研究院, 特任助教 2015: 千葉大学, 医学(系)研究科(研究院), 特任助教
Review Section/Research Field	Principal Investigator Surgical dentistry Except Principal Investigator Surgical dentistry
Keywords	Principal Investigator 口腔扁平上皮癌 / α5β3integrin / Angiopietin-like3 / α5β3インテグリン / Angiopoietin-like　3 / アデノシン受容体 / ADORA2B / 口腔癌 / HIF-1α / Theophylline … More / アデノシン / ADORA2b / HIF1α / HIF1-α … More Except Principal Investigator long non coding RNA / UCA1 / LINC00256A / 共培養 / 腫瘍の浸潤・転移能 / 放射線耐性試験 / 抗癌剤耐性試験 / 抗がん剤・放射線耐性 / 抗がん剤耐性試験 / lncRNA / 口腔癌 / miRNA / 口腔扁平上皮癌 / ALY / GAD1 / HTR2C / KLK13 / βcatenin / Wnt / Cadherin / カテニン / Wnt経路 / カドヘリン複合体 / カドヘリン / catenin / Lin7C Less

Development of cancer metastasis inhibitor by controlling cadherin complex and Wnt pathway via catenin
- Principal Investigator
  
  Tanzawa Hideki
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Surgical dentistry
- Research Institution
  Chiba University
Development of a novel cancer treatment to regulate the cancer progressive cascade starting from adenosine receptorPrincipal Investigator
- Principal Investigator
  
  MINAKAWA Yasuyuki
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Chiba University
Development of novel therapy based on functions of long non coding RNA in the cancer and cancer-associated cells
- Principal Investigator
  
  SHIIBA Masashi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Chiba University
Elucidation of the cancer progression through the a5b3 integrin pathway for establishment of a noval treatment for tumor growthPrincipal Investigator
- Principal Investigator
  
  MINAKAWA YASUYUKI
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Chiba University

All 2015

All Journal Article

[Journal Article] ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.2015
- Author(s)
  Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K
- Journal Title
  
  Cancer Med.
  
  Volume: 4 Pages: 759-69
- DOI
  10.1002/cam4.418
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K20502

1. 坂本洋右 (50451745)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 小河原克訓 (20372360)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. SHIIBA Masashi (20301096)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. Tanzawa Hideki (50236775)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

MINAKAWA YASUYUKI 皆川康之

Research Projects

Research Products

Co-Researchers

Development of cancer metastasis inhibitor by controlling cadherin complex and Wnt pathway via catenin

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of a novel cancer treatment to regulate the cancer progressive cascade starting from adenosine receptorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel therapy based on functions of long non coding RNA in the cancer and cancer-associated cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of the cancer progression through the a5b3 integrin pathway for establishment of a noval treatment for tumor growthPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.2015

Author(s)

Journal Title

DOI

Data Source

MINAKAWA YASUYUKI 皆川 康之

Research Projects

Research Products

Co-Researchers

Development of cancer metastasis inhibitor by controlling cadherin complex and Wnt pathway via catenin

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of a novel cancer treatment to regulate the cancer progressive cascade starting from adenosine receptorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel therapy based on functions of long non coding RNA in the cancer and cancer-associated cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of the cancer progression through the a5b3 integrin pathway for establishment of a noval treatment for tumor growthPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.2015

Author(s)

Journal Title

DOI

Data Source

MINAKAWA YASUYUKI 皆川康之